Under the proposed legislation, insurance plans must either set the copayments, deductibles or coinsurance amounts for oral ...

FDA Established April 23, 2026 as PDUFA Target Date for Review of Submission Seeking Approval for GTx-104 in the Treatment of Patients with aneurysmal Subarachnoid Hemorrhage (aSAH) Phase 3 STRIVE-ON ...

FDA Established April 23, 2026 as PDUFA Target Date for Review of Submission Seeking Approval for GTx-104 in the Treatment of Patients with ...

Dr. Dan Thomson shares essential tips for injections, needle selection and syringe maintenance to ensure herd health and ...

Countryfile ’s beloved presenter Julia Bradbury shared a major health update from a medical chair. Addressing her fans on Instagram, the 55-year-old was dressed down in a jumper and jeans, with one ...

A woman known by the nickname “injection aunt,” identified as Ms. A, drew attention after posting and later deleting a message seemingly targeting broadcaster Jun Hyun-moo. Ms. A has faced allegations ...

Addressing a Leading Cause of Hospitalization in Older Adults with Heart Failure BURLINGTON, Mass., Feb. 9, 2026 /PRNewswire/ -- SQ Innovation, Inc. today ...

SQ Innovation, Inc. today announced that following its FDA approval in October 2025, Lasix(R) ONYU (furosemide injection) is now available for ordering through Cardinal Health's Specialty ...

BIOA B (Stockholm: BIOA B) partner Eisai announced today that the Biologics License Application (BLA) for the treatment of early Alzheimer's disease with Leqembi (lecanemab), using a subcutaneous ...

Viehbacher, “Biogen”) announced today that the Biologics License Application (BLA) for the subcutaneous formulation (subcutaneous autoinjector: SC-AI) of “LEQEMBI ® ” (brand name in China: “??? ® ”, ...

Weiss, Chief Executive Officer and Chairman of TG Therapeutics stated, “We are pleased to share data at this year’s ACTRIMS annual meeting, including updates from the ENABLE real world study ...